BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29964136)

  • 1. An inhibitor screen identifies histone-modifying enzymes as mediators of polymer-mediated transgene expression from plasmid DNA.
    Christensen MD; Nitiyanandan R; Meraji S; Daer R; Godeshala S; Goklany S; Haynes K; Rege K
    J Control Release; 2018 Sep; 286():210-223. PubMed ID: 29964136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of mediators of intracellular trafficking on transgene expression efficacy of polymer-plasmid DNA complexes.
    Barua S; Rege K
    Biomaterials; 2010 Aug; 31(22):5894-902. PubMed ID: 20452664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The histone deacetylase inhibitor Entinostat enhances polymer-mediated transgene expression in cancer cell lines.
    Elmer JJ; Christensen MD; Barua S; Lehrman J; Haynes KA; Rege K
    Biotechnol Bioeng; 2016 Jun; 113(6):1345-1356. PubMed ID: 26614912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells.
    Huang Y; Vasilatos SN; Boric L; Shaw PG; Davidson NE
    Breast Cancer Res Treat; 2012 Feb; 131(3):777-89. PubMed ID: 21452019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgene expression efficiency from plasmid DNA delivered as a complex with histone H3.
    Kamiya H; Goto H; Kanda G; Yamada Y; Harashima H
    Int J Pharm; 2010 Jun; 392(1-2):249-53. PubMed ID: 20362041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG.
    Anastas JN; Zee BM; Kalin JH; Kim M; Guo R; Alexandrescu S; Blanco MA; Giera S; Gillespie SM; Das J; Wu M; Nocco S; Bonal DM; Nguyen QD; Suva ML; Bernstein BE; Alani R; Golub TR; Cole PA; Filbin MG; Shi Y
    Cancer Cell; 2019 Nov; 36(5):528-544.e10. PubMed ID: 31631026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinome-level screening identifies inhibition of polo-like kinase-1 (PLK1) as a target for enhancing non-viral transgene expression.
    Christensen MD; Elmer JJ; Eaton S; Gonzalez-Malerva L; LaBaer J; Rege K
    J Control Release; 2015 Apr; 204():20-9. PubMed ID: 25681050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importin-4 Regulates Gene Delivery by Enhancing Nuclear Retention and Chromatin Deposition by Polyplexes.
    Ross NL; Sullivan MO
    Mol Pharm; 2015 Dec; 12(12):4488-97. PubMed ID: 26465823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective DOT1L, LSD1, and HDAC Class I Inhibitors Reduce HOXA9 Expression in MLL-AF9 Rearranged Leukemia Cells, But Dysregulate the Expression of Many Histone-Modifying Enzymes.
    Lillico R; Lawrence CK; Lakowski TM
    J Proteome Res; 2018 Aug; 17(8):2657-2667. PubMed ID: 29972300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced transgene expression from chromatinized plasmid DNA in mouse liver.
    Kamiya H; Miyamoto S; Goto H; Kanda GN; Kobayashi M; Matsuoka I; Harashima H
    Int J Pharm; 2013 Jan; 441(1-2):146-50. PubMed ID: 23247018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of plasmid DNA copies in the nucleus after lipoplex and polyplex transfection.
    Cohen RN; van der Aa MA; Macaraeg N; Lee AP; Szoka FC
    J Control Release; 2009 Apr; 135(2):166-74. PubMed ID: 19211029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular barriers to non-viral gene transfer.
    Lechardeur D; Lukacs GL
    Curr Gene Ther; 2002 May; 2(2):183-94. PubMed ID: 12109215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficiency of nuclear plasmid DNA delivery is a critical determinant of transgene expression at the single cell level.
    Glover DJ; Leyton DL; Moseley GW; Jans DA
    J Gene Med; 2010 Jan; 12(1):77-85. PubMed ID: 19890943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3.
    Meng F; Sun G; Zhong M; Yu Y; Brewer MA
    Int J Oncol; 2013 Aug; 43(2):495-502. PubMed ID: 23709006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment.
    Duan YC; Ma YC; Qin WP; Ding LN; Zheng YC; Zhu YL; Zhai XY; Yang J; Ma CY; Guan YY
    Eur J Med Chem; 2017 Nov; 140():392-402. PubMed ID: 28987602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC5-LSD1 axis regulates antineoplastic effect of natural HDAC inhibitor sulforaphane in human breast cancer cells.
    Cao C; Wu H; Vasilatos SN; Chandran U; Qin Y; Wan Y; Oesterreich S; Davidson NE; Huang Y
    Int J Cancer; 2018 Sep; 143(6):1388-1401. PubMed ID: 29633255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [DNA methyltransferase inhibitors * histone deacetylase inhibitors].
    Kikuchi J; Furukawa Y
    Nihon Rinsho; 2014 Jun; 72(6):1136-42. PubMed ID: 25016817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone modifications are associated with the persistence or silencing of vector-mediated transgene expression in vivo.
    Riu E; Chen ZY; Xu H; He CY; Kay MA
    Mol Ther; 2007 Jul; 15(7):1348-55. PubMed ID: 17457320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone-Mimetic Gold Nanoparticles as Versatile Scaffolds for Gene Transfer and Chromatin Analysis.
    Munsell EV; Fang B; Sullivan MO
    Bioconjug Chem; 2018 Nov; 29(11):3691-3704. PubMed ID: 30350573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing expression level and stability of transgene mediated by episomal vector via buffering DNA methyltransferase in transfected CHO cells.
    Wang XY; Yi DD; Wang TY; Wu YF; Chai YR; Xu DH; Zhao CP; Song C
    J Cell Biochem; 2019 Sep; 120(9):15661-15670. PubMed ID: 31074065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.